Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcturus Therapeutics Holdings (ARCT) Gains from Investment Securities (2018 - 2025)

Arcturus Therapeutics Holdings' Gains from Investment Securities history spans 8 years, with the latest figure at $8.9 million for Q4 2025.

  • For Q4 2025, Gains from Investment Securities rose 1472.45% year-over-year to $8.9 million; the TTM value through Dec 2025 reached $8.9 million, up 168.75%, while the annual FY2025 figure was $8.9 million, 9.78% up from the prior year.
  • Gains from Investment Securities reached $8.9 million in Q4 2025 per ARCT's latest filing, up from $564000.0 in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $8.9 million in Q4 2025 to a low of -$35.3 million in Q3 2022.
  • Average Gains from Investment Securities over 5 years is -$909032.8, with a median of $1.5 million recorded in 2021.
  • Peak YoY movement for Gains from Investment Securities: crashed 203.26% in 2021, then skyrocketed 1472.45% in 2025.
  • A 5-year view of Gains from Investment Securities shows it stood at -$3.8 million in 2021, then skyrocketed by 275.07% to $6.7 million in 2022, then dropped by 28.16% to $4.8 million in 2023, then tumbled by 88.25% to $564000.0 in 2024, then surged by 1472.45% to $8.9 million in 2025.
  • Per Business Quant, the three most recent readings for ARCT's Gains from Investment Securities are $8.9 million (Q4 2025), $564000.0 (Q4 2024), and $2.7 million (Q1 2024).